1. ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer. (March 2019) Authors: Harbeck, N.; Gluz, O.; Christgen, M.; Graeser, M.; Hilpert, F.; Kreipe, H.H.; Nitz, U.; Kates, R.; Schinkoethe, T.; Kuemmel, S. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differential impact of prognostic parameters in hormone receptor-positive lobular early breast cancer in the WSG PlanB trial. (October 2020) Authors: Christgen, M.; Harbeck, N.; Gluz, O.; Raap, M.; Christgen, H.; Clemens, M.; Malter, W.; Nuding, B.; Aktas, B.; Kuemmel, S.; Reimer, T.; Stefek, A.; Krabisch, P.; Just, M.; Graeser, M.; Baehner, R.; Wuerstlein, R.; Nitz, U.; Kates, R.; Kreipe, H. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Five-year results of the prospective Phase III WSG PlanB trial confirm prognostic impact of 21-Gene Recurrence Score in high-risk HR+/HER2− early breast cancer (EBC) patients with 1-3 involved lymph nodes. (March 2017) Authors: Gluz, O.; Nitz, U.; Christgen, M.; Kates, R.; Clemens, M.; Nuding, B.; Shak, S.; Würstlein, R.; Kreipe, H.; Harbeck, N. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results. (March 2017) Authors: Wuerstlein, R.; Grischke, E.M.; Gluz, O.; Kates, R.; Persoon, M.; Thill, M.; Hasmueller, S.; Knauer, M.; Pusch, R.; Harbeck, N. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗